Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2024 08:30 ET | Source: Dyadic International, Inc.

Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications

The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman primate models compared to monoclonal antibody produced in CHO. ...
October 30, 2023 08:30 ET | Source: Dyadic International, Inc.

Dyadic to Present at Industry Events in November

Dyadic to Present at Industry Events in November
June 09, 2022 09:09 ET | Source: Dyadic International, Inc.

Dyadic to Participate in Three Upcoming Industry Events

JUPITER, Fla., June 09, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and...
April 04, 2022 08:30 ET | Source: Dyadic International, Inc.

Dyadic International to Present at Upcoming Scientific Medical Meetings

JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and...
December 17, 2021 07:00 ET | Source: Dyadic International, Inc.

Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform

JUPITER, Fla., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
June 15, 2021 13:01 ET | Source: Market Research Future

Protein Therapeutics Market Worth $ 290, 691.88 Million By 2027, at 6.86% CAGR – Report by Market Research Future (MRFR)

New York, US, June 15, 2021 (GLOBE NEWSWIRE) -- Protein Therapeutics Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Protein Therapeutics Market -...
October 23, 2017 08:00 ET | Source: Ventria Bioscience

Ventria Bioscience aids global fight against intestinal infections that threaten up to 400 million children a year

JUNCTION CITY, Kan., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Ventria Bioscience Inc. today announced a $4.2 million grant from the Bill & Melinda Gates Foundation to fund development of efficient...